Trials Currently Looking for Patients

AZURE D7960C00015 (Astra Zeneca)

Patients with LDL (bad cholesterol) over 100, and other risk factors like diabetes, smoking and high blood pressure

OCEAN(a) 20230222 (Amgen)

Looking for patients with Lp(a) >200 who have not had a stent or bypass surgery

PACIFIC D6972C00002 (Astra Zeneca)

Looking for patients with high blood pressure and kidney disease with protein in their urine

Current Clinical Trials

PREVAIL TA-8995-304 (New Amsterdam) 20604 (Bayer) Phase III January 2023-Present

Placebo Controlled, Double Blind, Randomized Cardiovascular Outcome Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With ASCVD Not Adequately Controlled Despite Maximally Tolerated Lipid Modifying Therapies. NCT05202509

GARDEN-TIMI 74 C3651011 (Pfizer). Phase II September 2022-Present

A Phase 2, double blind, randomized, placebo-controlled, 4 arm study to investigate symptoms, function, health-related quality of life and safety with repeated subcutaneous administration of prosegromab versus placebo in adult participants with heart failure. NCT05492500. **First Site to Enroll a Patient in the United States**

MARITIME-CV (AMGEN)-Indication:

Overweight (BMI >27) and History of either MI (Heart Attack), Stroke, Symptomatic Peripheral Artery Disease

ROXI-ATLAS (Regeneron)- Indication:

Atrial Fibrillation/Flutter and willing to take anticoagulant therapy

EASi-PROTKT (Boehringer Ingelheim)-Indication:

Type 2 Diabetes, Hypertension, History of Cardiovascular Disease without Heart Failure

HERMES (Novo Nordisk)-Indication:

Heart Failure with Preserved Ejection Fraction > 40% and elevated hs-CRP (inflammatory marker lab)

Dal-GenE-2 (DalCor Pharmaceuticals)- Indication:

MI (Heart Attack) with in the past 90 days

AMBER HFpEF (Cytokinetics)-Indication:

Ages 40 years to 85 years with Heart Failure with Preserved Ejection Fraction > 60%

BalanceD-HF (AstraZeneca)-Indication:

Chronic Kidney Disease, History of Heart Failure with Hospitalization or Urgent Care Visit for heart failure requiring IV medications for treatment within the past 6 months.

Research Focused
on Real-World
Health Needs.

We conduct clinical research across a wide range of medical conditions to advance treatment options and improve patient outcomes.

Our studies focus on conditions affecting everyday lives—helping move medicine forward while offering patients access to potential new therapies.

Atrial Fibrillation
Congestive Heart Failure
Hypercholesterolemia
Coronary Artery Disease
Atherosclerosis Cardiovascular Disease
Myocardial Infarction
Obesity
Cholesterol
Stroke

Request an Appointment

Find Studies Related to Your Condition.

The Process is Simple

1

Learn about
available studies.

2

Speak with
our research team.

3

Decide if participation
is right for you.

View Current Clinical Trials

Please Do Not Submit Medical Information

Request An Appointment:

Trials Currently Looking for Patients

Current Clinical Trials

Research Focused
on Real-World
Health Needs.

Our studies focus on conditions affecting everyday lives—helping move medicine forward while offering patients access to potential new therapies.

The Process is Simple

1

2

3

Get in touch

Our Location

Eastern Shore Research Institute, LLC

251.990.1920

info@heartgroupes.com

About

Please Do Not Submit Medical Information

Request An Appointment:

Trials Currently Looking for Patients

Current Clinical Trials

Research Focusedon Real-WorldHealth Needs.

Our studies focus on conditions affecting everyday lives—helping move medicine forward while offering patients access to potential new therapies.

The Process is Simple

1

2

3

Research Focused
on Real-World
Health Needs.